Dr Merit Cudkowicz
Sean M. Healey & AMG Center for ALS at Mass General Hospital, USA

Talk titles
"The REFALS phase 3 study of levosimendan in patients with ALS"
"NurOwn ALS Phase 3 clinical trial update" (co-presenter)

Dr. Merit Cudkowicz is the Director of the Healey Center for ALS, Chief of Neurology at Massachusetts General Hospital and the Julieanne Dorn Professor of Neurology at HMS. She is dedicated to the study and treatment of people with ALS. Healey Center for ALS, partnered with Tackle ALS, will lead the first Platform Trial initiative for ALS. Each trial evaluates only one drug at a time and requires lengthy start-up and execution times. Platform trials, instead, are trials where multiple drugs are tested at the same time, using specialized statistical tools.

She completed her undergraduate degree in chemical engineering at MIT and earned a medical degree at HMS. She completed her neurology residency and fellowship at Massachusetts General Hospital.